Abigail Johnson — all tracked 13F funds

Holdings and reported values are aggregated from the latest 13F filings of every fund entity managed under this manager.

Embed this top-holdings widget →

Fund Holdings (Q3 2026) Reported value
Fidelity Management & Research (FMR) 5518 $2,182.74B

🚩 Holdings Prediction Model (2026-Q3)

Next-quarter Top-10 holdings and weights predicted from historical holdings plus per-stock price/volume (no look-ahead). Shows the prediction and backtest accuracy for the manager's core fund .

Predicted Top 10 — Next Quarter (2026-Q4)

Loading forecast…

Historical backtest (19 quarters): avg precision 92% · recall 92% · F1 92%

Form 4 Insider Transactions

Transaction date Activity Security Shares Price Filing
2026-11-10 Sell Avalyn Pharma Inc. 47,889 $30.28 SEC filing
2026-11-10 Sell Avalyn Pharma Inc. 5,565 $29.56 SEC filing
2026-11-09 Sell Avalyn Pharma Inc. 1,339 $29.75 SEC filing
2026-11-09 Sell Avalyn Pharma Inc. 173,661 $29.06 SEC filing
2026-06-26 Sell Beam Therapeutics Inc. 251,488 $35.26 SEC filing
2026-06-25 Sell Beam Therapeutics Inc. 33,372 $35.12 SEC filing
2026-05-01 Conversion Avalyn Pharma Inc. 377,948 — SEC filing
2026-05-01 Conversion Avalyn Pharma Inc. 225,843 — SEC filing
2026-05-01 Conversion Avalyn Pharma Inc. 872,868 — SEC filing
2026-05-01 Conversion Avalyn Pharma Inc. 80,291 — SEC filing

Insider transactions (Form 4) →

Why several funds per manager?

The SEC attributes a 13F filing to the management company with investment discretion. Big managers run multiple entities — hedge fund, advisers arm, private-investments vehicle — each filing separately. This page groups them so the manager-level picture is not split across filings. Who must file a 13F →

Where to go next

All fund managers → · Insider Transactions · Star manager new positions → · Browse all tracked funds →